Member Info for Uncanny

Filtered now

Flipsome Well of course it works mate which is why we are in clinical trials now. If it didn’t VAL wouldn't be in the advanced stage of completing CTl/ll. The escalation if mg will hopefully shoe the optimum dosage to date expected by EOY.

Edinburgh last week.

Freddie Just shows their desperation as developments and the release of shareholfer value are now finally coming to a conclusion. Their relentess posts is a barometer that good things are coming to VAL. I must say I am surprised why everyone does not filter them as by responding you are just adding fuel to their agenda. Hopefully a turn in the price now as 401 in confirmed talks with 6 parties and 201 release soon which should be a repeat of last December. I also think the fortunes have changed here whereby good news will lead to a growing sustainable share price as opposed to previously where pi’s ran for the hills in to any strength. With 401 deal, the funding issue dies, being the markets biggest fear and commercialisation is where we are from junior r’n’d bio company. GLA and hopefully climb in to the 2p and 3p range ahead of positive 201 escalation data, which as a compound is a game changer for VAL

6 parties Isleworrh according to the Edinburgh presenatation feedback here from Cream.

Thanks Jonbhoy. Yes, I think everything is now bubbling along nicely for VAL, whoch is why I am increasing my holding.

Fair enough but a very different story to some on here saying a 401 deal has collapsed, quite the contrary and there are obviously willing buyers of the compound so they see value in 401 as a commercial product!

Isn’t that what GM said to cream - in talks with 6 and 2 have territorial differences to settle. Is that not a deal in progress?

What did I say that was wrong?

Personally I’m not expecting any news to coincide with tonights presentation, but happy to be proved wrong.

Because its a closed period until a deal is signed - you won’t get a murmur from any party as it would jeopardise any deal going forward because of NDA’s. It will have to be by formal RNS. Patience. The Twitter tweet said Suzy in Boston with Entralta..... interesting!

If it went to 70p quickly I’d end up in A&E! Good buying yesterday and today..... things coming to a head now IMHO. Could easily 5 to10 bag with the right news.

BritBD - Read the last RNS: Lords and our CEO Adam - there is no value until they commercialise, no income, no didly squat. Thats where we are right now with 401.

Adam I didn’t say I didn’t want the BoD to perform, of course I do but its the compounds that will do the talking here. We could have the most astute and savvy CEO at the helm, but without the goods, we have nothing! The only winners to date here were those in at 1p and out at 7p last December, everyone else is down (including me) but I like the science and prepared to stick with it. Late 2017 and 2018 has been transformational for VAL. Share holder value will filter through in time IMHO, but support the company, don’t slate it or you are simply guilty of disseminating bad PR for your own investment.

Kane, yes I noticed the Lords crowd - very interesting??!!! Coupled with China presentation, Munich, Edinburgh and Hardman plus Align report just shows GM et al are lining up their ducks with the market, their peers and the general industry.

I don’t want the BoD to perform, l want the compounds to perform! That is what we are buying here, onocology drugs. Look through the last 2 years RNS’s..... when did we have a bad one? VAL are getting towards the end game now. Disgruntled investors, simply bought at the wrong time when the company was burning cash at a phenominal rate. Things are now very different as they near commercialisation. GLA

An RNS will not be issued by default just because there is an investor presentation. VAL can’t just summon news from no where, LOL. If there is news then great, but l doubt it nor expect it.

Adam, I aleays email the company and always get a quick response on all - the good,the bad and the ugly.

wtf!

Hi Noise I bow to your knowledge on LNCap. Whilst 401 is excellent and hopefully a funding gap, 201 is a game changer and could transfer this company from microcap to SME. GLA